KINGFA NSE filing

Kingfa India Q3FY26: ₹115.15 Cr Utilized from ₹500 Cr Preferential Issue

The RealCase readLow impact Neutral

Kingfa Science & Technology (India) Limited utilized ₹115.15 crore from its ₹500 crore preferential issue in Q3FY26. ₹60.29 crore went to plant and machinery, and ₹54.86 crore to general corporate purposes. ₹384.85 crore remains unutilized, invested in fixed deposits.

Why it matters

This is a routine compliance filing and does not contain any new operational or financial performance data that would significantly impact the company's stock or investor decisions.

The market read

The report is a routine monitoring agency update on fund utilization. While the utilization is as per plan and there are no deviations, the significant unutilized amount, although invested, does not present a strongly positive or negative outlook.

Kingfa Science & Technology (India) Limited has submitted its Monitoring Agency Report for the quarter ended December 31, 2025, concerning the utilization of proceeds from its preferential issue of ₹500 crore.

The report, issued by CARE Ratings Limited, indicates that during the third quarter of FY26, the company utilized ₹115.15 crore. Specifically, ₹60.29 crore was used for the procurement of plant and machinery, and ₹54.86 crore was allocated for General Corporate Purposes (GCP).

As of December 31, 2025, the total utilized amount stands at ₹115.15 crore, with ₹384.85 crore remaining unutilized. The unutilized proceeds have been invested in fixed deposits with ICBC, earning interest at rates ranging from 5.65% to 6.05% per annum, with a total market value of ₹390.20 crore as of the reporting date.

There were no deviations observed from the objects disclosed in the Offer Document. The company has also confirmed that all necessary government and statutory approvals will be obtained as and when required. The planned completion date for all major objects, including factory construction and land acquisition, is June 2027, with no delays reported.

Filing to action

What to do with a filing like this

Kingfa Science & Technology (India) Limited filed this with the NSE as a statutory disclosure, categorised under debt fundraising. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.

That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.

See the model portfolios
Primary source

A plain-language summary of a public exchange filing by Kingfa Science & Technology (India) Limited. Read the original for the full detail.

View original filing